Cerebral Vascular Smooth Muscle Cells

📖 Wiki Page

cell1478 wordssynced 2026-04-02

Cerebral Vascular Smooth Muscle Cells

Overview

flowchart TD Cerebral_Vascular_Smooth_Muscl["Cerebral Vascular Smooth Muscle Cells"] Cerebral_Vascular_Smooth_Muscl["table"] Cerebral_Vascular_Smooth_Muscl -->|"related to"| Cerebral_Vascular_Smooth_Muscl style Cerebral_Vascular_Smooth_Muscl fill:#81c784,stroke:#333,color:#000 Cerebral_Vascular_Smooth_Muscl["class"] Cerebral_Vascular_Smooth_Muscl -->|"related to"| Cerebral_Vascular_Smooth_Muscl style Cerebral_Vascular_Smooth_Muscl fill:#81c784,stroke:#333,color:#000 Cerebral_Vascular_Smooth_Muscl["infobox"] Cerebral_Vascular_Smooth_Muscl -->|"related to"| Cerebral_Vascular_Smooth_Muscl style Cerebral_Vascular_Smooth_Muscl fill:#81c784,stroke:#333,color:#000 style Cerebral_Vascular_Smooth_Muscl fill:#4fc3f7,stroke:#333,color:#000

...

Cerebral Vascular Smooth Muscle Cells

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cerebral Vascular Smooth Muscle Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000359](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000359)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000359](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000359)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">alpha-Smooth Muscle Actin (alphaSMA)</td>
<td>Contractile apparatus</td>
</tr>
<tr>
<td class="label">Smooth Muscle Myosin Heavy Chain (SM-MHC)</td>
<td>Force generation</td>
</tr>
<tr>
<td class="label">Calponin</td>
<td>Actin binding</td>
</tr>
<tr>
<td class="label">SM22alpha</td>
<td>Cytoskeletal organization</td>
</tr>
<tr>
<td class="label">Vimentin</td>
<td>Intermediate filament</td>
</tr>
<tr>
<td class="label">Desmin</td>
<td>Force transmission</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Calcium channel blockers</td>
<td>Reduce Ca2+ influx</td>
</tr>
<tr>
<td class="label">ACE inhibitors/ARBs</td>
<td>Reduce Ang II</td>
</tr>
<tr>
<td class="label">Statins</td>
<td>Pleiotropic effects</td>
</tr>
<tr>
<td class="label">PDE5 inhibitors</td>
<td>Enhance cGMP</td>
</tr>
<tr>
<td class="label">Endothelin antagonists</td>
<td>Block ETA/ETB</td>
</tr>
</table>

Cerebral Vascular Smooth Muscle Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Cerebral vascular smooth muscle cells (cVSMCs) are specialized contractile cells that line the walls of cerebral arteries, arterioles, and small arteries within the brain. These cells play essential roles in regulating cerebral blood flow (CBF), maintaining the blood-brain barrier (BBB), and supporting brain homeostasis["@iadecola2004"][@rubin2007]. cVSMC dysfunction is increasingly recognized as a critical contributor to neurodegenerative processes in Alzheimer's disease (AD), Parkinson's disease (PD), vascular dementia, and other neurological disorders["@zlokovic2011"][@guajardocorrea2022].

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000359)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000359)
[OBO Foundry (CL:0000359)](http://purl.obolibrary.org/obo/CL_0000359)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000359)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000359)
[OBO Foundry (CL:0000359)](http://purl.obolibrary.org/obo/CL_0000359)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Introduction

The cerebral vasculature contains approximately 100 billion capillary endothelial cells supported by pericytes and surrounded by astrocyte end-feet, all of which work in concert with cVSMCs to maintain optimal brain function. Unlike peripheral vascular smooth muscle cells, cVSMCs exhibit unique phenotypic characteristics that reflect their specialized role in neural tissue perfusion[@iadecola2004]. These cells respond to neural activity through neurovascular coupling, ensuring that energy demands of active neurons are met through increased blood flow.

The importance of cVSMCs in neurodegeneration has become increasingly apparent through research linking vascular risk factors to cognitive decline and demonstrating that cerebrovascular pathology precedes or accompanies hallmark proteinopathies in AD and PD[@zlokovic2011][@guajardocorrea2022]. Understanding cVSMC biology provides crucial insights into disease mechanisms and identifies potential therapeutic targets.

Anatomy and Structure

Vascular Architecture

The cerebral arterial tree consists of distinct compartments, each with characteristic cVSMC populations[@iadecola2004][@rubin2007]:

Large cerebral arteries (internal carotid, basilar, middle cerebral): Thick media layer with multiple cVSMC layers

Pial arteries (on brain surface): Single to few cVSMC layers, ensheathed by leptomeninges

Penetrating arterioles (into brain parenchyma): Single cVSMC layer, direct astrocyte contact

Intracerebral arterioles: Transition to pericyte-dominated capillaries

Cellular Morphology

cVSMCs exhibit a distinctive contractile phenotype characterized by:

Elongated, spindle-shaped cell bodies oriented circumferentially around vessels
Dense myosin and actin filaments organized into contractile units
Abundant rough endoplasmic reticulum for protein synthesis
Surface caveolae containing receptors and ion channels
Myoendothelial junctions connecting to endothelial cells[@rubin2007]

Key Structural Proteins

Molecular Biology

Ion Channels and Receptors

cVSMC function depends on precisely regulated ion channel expression[@rubin2007][@brozovich2016]:

Calcium signaling:

L-type Cav1.2 channels: Primary voltage-gated calcium entry
R-type Cav2.3 channels: Sustained calcium influx
T-type Cav3.1/3.2 channels: Depolarization-induced calcium release
IP3 receptors: Calcium release from internal stores
BK and SK channels: Calcium-activated potassium efflux

Contractile receptors:

α1-adrenergic receptors: Sympathetic vasoconstriction
Endothelin receptors (ETA/ETB): Potent vasoconstriction
Angiotensin II receptors (AT1): Pressure regulation
Serotonin receptors (5-HT2): Vasoconstriction
Prostaglandin receptors: Vasodilation/constriction balance

Relaxing receptors:

β-adrenergic receptors: Sympathetic vasodilation
Nitric oxide receptors (sGC): cGMP-mediated relaxation
Adenosine receptors (A2A/A2B): Metabolic vasodilation

Signaling Pathways

Key intracellular signaling cascades in cVSMCs:

Calcium-calmodulin-MLCK pathway: Primary contraction mechanism

RhoA/ROCK pathway: Calcium sensitization and stress fiber formation

MAPK pathways: Growth, proliferation, and survival

PI3K/Akt pathway: Cell survival and protein synthesis

cAMP/PKA pathway: Relaxation and inhibition of contraction[@brozovich2016]

Transcription Factors

SRF (Serum Response Factor): Master regulator of contractile gene program
Myocardin: Co-activator of SRF, drives differentiation
KLF4: Phenotypic switching regulator
Notch3: Critical for cVSMC development and CADASIL[@joutel1996]

Function in Cerebral Circulation

Autoregulation

cVSMCs maintain constant CBF across a wide range of systemic blood pressures (approximately 60-150 mmHg mean arterial pressure)[@iadecola2004][@rubin2007]:

Myogenic response: Intrinsic vessel response to pressure changes
Rapid adaptation: Seconds to minutes timescale
Impairment: Leads to hyper-/hypoperfusion injuries
Age-related decline: Autoregulatory range narrows

Neurovascular Coupling

Activity-dependent blood flow regulation requires cVSMC coordination[@iadecola2004][@zlokovic2011]:

Active neurons release vasoactive substances (glutamate, ATP, norepinephrine)

Astrocyte end-feet detect signals and release prostaglandins/EETs

cVSMCs respond with dilation (increased blood flow) or constriction

Feedforward signals prepare vessels for anticipated demand

Blood-Brain Barrier Support

cVSMCs contribute to BBB integrity through[@rubin2007]:

Structural support: Maintaining vessel wall integrity
Pericyte recruitment: Secretion of PDGF-BB for pericyte function
Tight junction regulation: Supporting endothelial barrier properties
Transport regulation: Controlling paracellular and transcellular passage

Role in Neurodegenerative Diseases

cVSMC dysfunction is central to the [neurovascular unit](/mechanisms/neurovascular-coupling) damage seen in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [vascular dementia](/diseases/vascular-dementia), interacting with [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau) pathology.

Alzheimer's Disease (AD)

cVSMC dysfunction represents a major contributor to vascular cognitive impairment and interacts with AD pathology[@zlokovic2011][@kelley2020]:

Mechanisms:

Cerebral amyloid angiopathy (CAA): Aβ deposition in cVSMC membranes leads to:
Loss of cVSMC viability and function
Impaired vasodilation and autoregulation
Increased risk of hemorrhagic stroke
Reduced clearance of Aβ from brain interstitial fluid[@kelley2020]
Vessel rarefaction: Progressive loss of cerebral vessels reduces CBF
White matter hypoperfusion: Contributing to white matter lesions
Neurovascular uncoupling: Impaired functional hyperemia

Clinical manifestations:

Reduced cerebral blood flow, particularly in posterior regions
White matter hyperintensities on MRI
Mixed dementia (vascular + AD pathology)
Increased sensitivity to blood pressure fluctuations

Therapeutic targets:

Aβ immunization and anti-aggregates
Vasculoprotective agents
Angiotensin receptor blockers (AT1)
PDE inhibitors to enhance cGMP signaling[@kelley2020]

Parkinson's Disease (PD) and Lewy Body Dementia

cVSMC involvement in [PD](/diseases/parkinsons-disease) and [Lewy body dementia](/diseases/lewy-body-dementia) involves [alpha-synuclein](/proteins/alpha-synuclein) pathology and [neuroinflammation](/mechanisms/neuroinflammation), with parallels to [cerebral amyloid angiopathy](/diseases/cerebral-amyloid-angiopathy) in AD.

Mechanisms:

α-Synuclein pathology: Lewy bodies in cVSMCs affect function
Cerebrovascular dysfunction: Precedes motor symptoms in some cases
Blood-brain barrier disruption: Increased permeability
Reduced vasodilatory capacity: Endothelial and cVSMC dysfunction

Clinical manifestations:

Reduced cerebral blood flow in basal ganglia
Orthostatic hypotension due to autonomic dysfunction
Increased stroke risk
Cognitive impairment from vascular contributions

Vascular Dementia

cVSMC dysfunction is central to vascular cognitive impairment[@gorelick2011]:

Small vessel disease: cVSMC degeneration in penetrating arterioles
White matter lesions: Hypoperfusion-driven demyelination
Lacunar infarcts: cVSMC failure and vessel occlusion
Binswanger's disease: Subcortical leukoaraiosis

CADASIL

Notch3 mutations cause hereditary cVSMC degeneration[@joutel1996][@chabriat2009]:

Notch3 extracellular domain accumulation in cVSMC membranes
Progressive vessel wall thickening and lumen narrowing
Characteristic MRI changes: White matter lesions, lacunes
Clinical features: Migraine, strokes, cognitive decline

Therapeutic Approaches

Current Pharmacological Strategies

Emerging Therapies

Gene therapy: AAV-delivered neurotrophic factors (BDNF, NGF)
Stem cell therapy: cVSMC progenitors for vessel repair
Antisense oligonucleotides: Targeting pathological gene expression
BBB-penetrant antioxidants: Reducing oxidative stress[@kelley2020]

Overview

Background

The study of Cerebral Vascular Smooth Muscle Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[Brain Cell Atlas](https://www.braincellinfo.org)
[Allen Brain Map](https://www.brain-map.org)
[NIH - Cell Types Database](https://www.ninds.nih.gov)

References

brozovich2016, Mechanisms of vascular smooth muscle contraction (2016) (2016)
chabriat2009, CADASIL (2009) (2009)
faucheux2003, Alpha-synuclein in cerebral vessels (2003) (2003)
gorelick2011, Vascular cognitive impairment (2011) (2011)
guajardocorrea2022, Cerebrovascular dysfunction in PD (2022) (2022)
iadecola2004, Iadecola C, Neurovascular regulation in the normal brain and in AD (2004) (2004)
joutel1996, Notch3 mutations in CADASIL (1996) (1996)
kelley2020, Kelley RE, Cerebral amyloid angiopathy in AD (2020) (2020)
rubin2007, Rubin LL, The blood-brain barrier (2007) (2007)
zlokovic2011, Zlokovic BV, Neurovascular pathways to neurodegeneration in AD (2011) (2011)

📖 View canonical wiki page →